BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34522028)

  • 61. The PLAGL2/MYCN/miR-506-3p interplay regulates neuroblastoma cell fate and associates with neuroblastoma progression.
    Zhao Z; Shelton SD; Oviedo A; Baker AL; Bryant CP; Omidvarnia S; Du L
    J Exp Clin Cancer Res; 2020 Feb; 39(1):41. PubMed ID: 32087738
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Properties of a polyamine transporter regulated by antizyme.
    Sakata K; Kashiwagi K; Igarashi K
    Biochem J; 2000 Apr; 347 Pt 1(Pt 1):297-303. PubMed ID: 10727431
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Yeast antizyme mediates degradation of yeast ornithine decarboxylase by yeast but not by mammalian proteasome: new insights on yeast antizyme.
    Porat Z; Landau G; Bercovich Z; Krutauz D; Glickman M; Kahana C
    J Biol Chem; 2008 Feb; 283(8):4528-34. PubMed ID: 18089576
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Orally bioavailable CDK9/2 inhibitor shows mechanism-based therapeutic potential in MYCN-driven neuroblastoma.
    Poon E; Liang T; Jamin Y; Walz S; Kwok C; Hakkert A; Barker K; Urban Z; Thway K; Zeid R; Hallsworth A; Box G; Ebus ME; Licciardello MP; Sbirkov Y; Lazaro G; Calton E; Costa BM; Valenti M; De Haven Brandon A; Webber H; Tardif N; Almeida GS; Christova R; Boysen G; Richards MW; Barone G; Ford A; Bayliss R; Clarke PA; De Bono J; Gray NS; Blagg J; Robinson SP; Eccles SA; Zheleva D; Bradner JE; Molenaar J; Vivanco I; Eilers M; Workman P; Lin CY; Chesler L
    J Clin Invest; 2020 Nov; 130(11):5875-5892. PubMed ID: 33016930
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Crystal structure of human ornithine decarboxylase at 2.1 A resolution: structural insights to antizyme binding.
    Almrud JJ; Oliveira MA; Kern AD; Grishin NV; Phillips MA; Hackert ML
    J Mol Biol; 2000 Jan; 295(1):7-16. PubMed ID: 10623504
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Degradation of ornithine decarboxylase: exposure of the C-terminal target by a polyamine-inducible inhibitory protein.
    Li X; Coffino P
    Mol Cell Biol; 1993 Apr; 13(4):2377-83. PubMed ID: 8455617
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A Novel MYCN-Specific Antigene Oligonucleotide Deregulates Mitochondria and Inhibits Tumor Growth in MYCN-Amplified Neuroblastoma.
    Montemurro L; Raieli S; Angelucci S; Bartolucci D; Amadesi C; Lampis S; Scardovi AL; Venturelli L; Nieddu G; Cerisoli L; Fischer M; Teti G; Falconi M; Pession A; Hrelia P; Tonelli R
    Cancer Res; 2019 Dec; 79(24):6166-6177. PubMed ID: 31615807
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Regulation of polyamine homeostasis through an antizyme citrullination pathway.
    Yang YF; Lee CY; Hsieh JY; Liu YL; Lin CL; Liu GY; Hung HC
    J Cell Physiol; 2021 Aug; 236(8):5646-5663. PubMed ID: 33432662
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Degrons of yeast and mammalian ornithine decarboxylase enzymes make potent combination for regulated targeted protein degradation.
    Joshi RG; Ratna Prabha C
    Appl Microbiol Biotechnol; 2017 Apr; 101(7):2905-2917. PubMed ID: 28013404
    [TBL] [Abstract][Full Text] [Related]  

  • 70. LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene.
    Ambrosio S; Amente S; Saccà CD; Capasso M; Calogero RA; Lania L; Majello B
    Oncotarget; 2017 Jan; 8(3):3854-3869. PubMed ID: 27894074
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The expression of ELOVL4, repressed by MYCN, defines neuroblastoma patients with good outcome.
    Rugolo F; Bazan NG; Calandria J; Jun B; Raschellà G; Melino G; Agostini M
    Oncogene; 2021 Sep; 40(38):5741-5751. PubMed ID: 34333551
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Regulation of ornithine decarboxylase activity and polyamine transport by agmatine in rat pulmonary artery endothelial cells.
    Babál P; Ruchko M; Campbell CC; Gilmour SP; Mitchell JL; Olson JW; Gillespie MN
    J Pharmacol Exp Ther; 2001 Feb; 296(2):372-7. PubMed ID: 11160620
    [TBL] [Abstract][Full Text] [Related]  

  • 73. p19-INK4d inhibits neuroblastoma cell growth, induces differentiation and is hypermethylated and downregulated in MYCN-amplified neuroblastomas.
    Dreidax D; Bannert S; Henrich KO; Schröder C; Bender S; Oakes CC; Lindner S; Schulte JH; Duffy D; Schwarzl T; Saadati M; Ehemann V; Benner A; Pfister S; Fischer M; Westermann F
    Hum Mol Genet; 2014 Dec; 23(25):6826-37. PubMed ID: 25104850
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Antizyme 3 inhibits polyamine uptake and ornithine decarboxylase (ODC) activity, but does not stimulate ODC degradation.
    Snapir Z; Keren-Paz A; Bercovich Z; Kahana C
    Biochem J; 2009 Apr; 419(1):99-103, 1 p following 103. PubMed ID: 19076071
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The antizyme family: polyamines and beyond.
    Mangold U
    IUBMB Life; 2005 Oct; 57(10):671-6. PubMed ID: 16223706
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Synergistic drug combination GC7/DFMO suppresses hypusine/spermidine-dependent eIF5A activation and induces apoptotic cell death in neuroblastoma.
    Schultz CR; Geerts D; Mooney M; El-Khawaja R; Koster J; Bachmann AS
    Biochem J; 2018 Jan; 475(2):531-545. PubMed ID: 29295892
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Metabolic and antiproliferative consequences of activated polyamine catabolism in LNCaP prostate carcinoma cells.
    Kee K; Vujcic S; Merali S; Diegelman P; Kisiel N; Powell CT; Kramer DL; Porter CW
    J Biol Chem; 2004 Jun; 279(26):27050-8. PubMed ID: 15096507
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Antizyme, a protein induced by polyamines, accelerates the degradation of ornithine decarboxylase in Chinese-hamster ovary-cell extracts.
    Murakami Y; Tanaka K; Matsufuji S; Miyazaki Y; Hayashi S
    Biochem J; 1992 May; 283 ( Pt 3)(Pt 3):661-4. PubMed ID: 1590755
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Translation efficiency affects the sequence-independent +1 ribosomal frameshifting by polyamines.
    Oguro A; Shigeta T; Machida K; Suzuki T; Iwamoto T; Matsufuji S; Imataka H
    J Biochem; 2020 Aug; 168(2):139-149. PubMed ID: 32181810
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Polyamine regulation of ornithine decarboxylase and its antizyme in intestinal epithelial cells.
    Yuan Q; Ray RM; Viar MJ; Johnson LR
    Am J Physiol Gastrointest Liver Physiol; 2001 Jan; 280(1):G130-8. PubMed ID: 11123206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.